nattiase® at Health Food Expo 2026

Unveils Neuroprotection Breakthrough at

Health Food Expo 健食原料。OEM 2026,

Expanding from Cardiovascular to Brain Health

At Tokyo’s leading nutraceutical event, nattiase® and CellMark Japan combine premium ingredient positioning with new scientific evidence, signaling a category shift toward cognitive health applications.

Tokyo, Japan — April 16–17, 2026

nattiase® will exhibit at Health Food Expo 2026 (健食原料・OEM展 2026) at Tokyo International Forum, Hall E1 (Glass Building, B2F), alongside its exclusive partner in Japan, CellMark Japan (セルマーク・ジャパン株式会社). At Booth B03–04, the brand will present its “Flow of Life” concept while showcasing its highest-activity premium nattokinase and newly released pre-clinical research.

As one of Japan’s key B2B nutraceutical platforms, the event brings together ingredient innovation, formulation strategy, and regulatory-forward product development.

From Premium Ingredient to Next-Gen Positioning

At the booth, nattiase® highlights its high-activity nattokinase specification designed for cardiovascular health, circulation support, and healthy aging applications.

More importantly, the brand is advancing beyond its traditional positioning—leveraging new scientific findings to expand into brain health and cognitive support, aligning with fast-growing global demand for neuroprotective solutions.

Scientific Unveil: G01 Opening Session Sets the Tone

The strategic shift was formally introduced during the G01 opening session (10:10–10:35, Seminar Room 5), where CellMark Japan presented new evidence on nattokinase’s neuroprotective potential.

The G-session track focuses on next-generation functional foods driven by science, efficacy perception, and regulatory readiness—making G01 a key signal of where the industry is heading.

Dual-Model Evidence Strengthens Credibility

The presentation was built on two peer-reviewed studies published in In Vivo, demonstrating consistent neuroprotective effects:

• Alzheimer’s Disease Model
“Protective Effects of Nattokinase on Alzheimer’s Disease Model Induced by Aluminum and D-Galactose”
→ Reduced amyloid accumulation, preserved brain structure, improved cognitive indicators

• MCAO Stroke Model
“Nattokinase Attenuates Cerebral Ischemia-Reperfusion Injury via Antioxidant Mechanisms”
→ Reduced infarct size and activation of antioxidant defense pathways

These findings position nattokinase as a candidate ingredient for both chronic neurodegeneration and acute brain injury support.

Flow of Life: From Science to Market Narrative

At Booth B03–04, visitors can explore how nattiase® translates ingredient science into scalable product concepts:

• Cardiovascular and blood flow support
• Healthy aging formulations
• Emerging brain health and cognitive positioning

Together with CellMark Japan, the brand aims to connect with partners seeking differentiated, science-backed ingredients for the Japanese market.

A Strategic Window Opens

As the nutraceutical industry shifts toward evidence-driven and experience-led solutions, ingredients with established safety and upgraded scientific narratives are gaining disproportionate advantage.

nattiase® is stepping into this gap—bridging cardiovascular heritage with brain health innovation, and turning a familiar ingredient into a higher-value platform. For brands looking to move beyond incremental formulations, the opportunity is no longer just about what ingredients you use, but how far you can take them.

🔎About the Presentation

Session: G01 (Opening Session, G Track) / Booth: B03-B04
Time: 10:10 – 10:35
Event: Health Food Expo 健食原料。OEM 2026
Presenter: Ayako Ishii, Sales Director, CellMark Japan